Related Articles
Tumour vaccines expressing IL-2, CD80, and IL-2 plus CD80 gene
IL-2 as adjuvant for vaccination with cells malignantly converted by HPV 16 or 3-MC
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16.
CYTOKINE GENE-MODIFIED VACCINES FOR IMMUNOTHERAPY OF CANCER (REVIEW)
Interleukin 15 augments antitumor activity of cytokine gene-modified melanoma cell vaccines in a murine model